## EQR: Equity Residential - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -1.2% below STRENGTH zone (4.0-10.0%); PEG 8.15 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($59.06)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. JPMorgan Chase & Co. Lowers Equity Residential (NYSE:EQR) Price Target to $71.00**
- Source: MarketBeat | 20251205T150737 | Neutral | Relevance: 100%
- JPMorgan Chase & Co. has reduced its price target for Equity Residential (NYSE:EQR) from $75.00 to $71.00 while maintaining a "neutral" rating, indicating a potential upside of 13.78%. The consensus among analysts is a "Hold" rating with an average target price of $70.02. Equity Residential recently reported Q3 EPS of $1.02, in line with estimates, and provided FY2025 guidance of 3.98â€“4.02 EPS.

**2. Panagora Asset Management Inc. Decreases Stock Holdings in Equity Residential $EQR**
- Source: MarketBeat | 20251204T020916 | Neutral | Relevance: 100%
- Panagora Asset Management Inc. significantly reduced its stake in Equity Residential (NYSE:EQR) by 26.7% in Q2, selling 246,479 shares and retaining 676,605 shares valued at $45.66 million. Despite this, institutional ownership remains high at 92.68%, with some institutions like Norges Bank increasing their positions. Analysts maintain a consensus "Hold" rating for EQR with a price target of $70.27 against a current share price of $61.47, highlighting the stock's 4.5% dividend yield and FY2025 EPS guidance.

**3. Schroder Investment Management Group Sells 210,220 Shares of Equity Residential $EQR**
- Source: MarketBeat | 20251203T050824 | Neutral | Relevance: 100%
- Schroder Investment Management Group significantly reduced its stake in Equity Residential (NYSE:EQR) by 18.9%, selling 210,220 shares and retaining 900,779 shares valued at approximately $60.79 million. Equity Residential reported Q3 EPS of $1.02, meeting estimates, and offered FY2025 EPS guidance, while analyst sentiment remains mixed with a consensus "Hold" rating. The company pays an annualized dividend of $2.77, representing a 4.5% yield.

**4. Mid-America Apartment (MAA) Stock Analysis Report | Ratings, Financials & Performance**
- Source: Benzinga | 20251203T042210 | Neutral | Relevance: 65%
- This report provides a comprehensive analysis of Mid-America Apartment (MAA) stock, covering its ratings, financials, and performance. It includes details on the company's segments, Benzinga Edge rankings for growth, value, momentum, and quality, and peer comparisons. The analysis also features future growth estimates, recent analyst ratings, valuation insights including earnings history and financial health metrics, dividend performance, and past stock performance using the Sharpe ratio, alongside detailed income, balance sheet, and cash flow statements.

**5. AvalonBay Communities (AVB): Assessing Valuation After Credit Outlook Upgrade and $400 Million Notes Offering**
- Source: Simply Wall Street | 20251204T125419 | Somewhat-Bullish | Relevance: 65%
- AvalonBay Communities (AVB) recently received a credit outlook upgrade from S&P Global and issued $400 million in senior notes, highlighting its balance sheet strength. Despite recent share price gains, the stock remains undervalued compared to analyst targets and intrinsic value, with a fair value estimated at $205.88. Investors are weighing these positive developments against broader REIT headwinds and potential risks like slower job growth and regulatory challenges.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 6)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-25 | Barclays | $77 | $80 | -4% |
| 2025-11-24 | Mizuho | $65 | $66 | -2% |
| 2025-11-17 | Truist Securiti | $70 | $75 | -7% |
| 2025-11-13 | Morgan Stanley | $74 | $75 | -2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-25 | Barclays | main | Overweight |
| 2025-11-24 | Mizuho | main | Neutral |
| 2025-11-17 | Truist Securiti | main | Buy |
| 2025-11-13 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 15.1% (+2.3%)
- Blackrock Inc.: 10.2% (+1.1%)
- State Street Corpora: 6.6% (+2.8%)
- Price (T.Rowe) Assoc: 5.2% (-4.5%)
- Apg Asset Management: 3.0% (-0.7%)

### Key Risks

1. Valuation stretched: PEG 8.2x requires aggressive growth execution.
2. Long-term trend broken: trading 7.8% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 8.15 signals overvaluation risk, limited margin of safety. Forward P/E 42.2x stretched relative to 7% growth. Quality metrics strong (margin 38%). Analyst sentiment negative (6 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $24.8B |
| Beta | 0.76 |
| 52W Range | $58.38 - $75.86 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 8.15 |
| Forward P/E | 42.2 |
| Current P/E | 45.3 |
| YoY Growth | 7.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.5% to -1.2% (-2.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.2pp (needs >4.0% for momentum thesis). Below SMA200 (0.92x), long-term trend not supportive. RSI neutral at 51. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.20% (CS: 44) | Neutral |
| RSI_14 | 50.8 | Neutral |
| MACD Histogram | 0.27 | Bullish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 0.995x | Below |
| vs SMA200 | 0.922x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $61.06
- **Stop Loss:** $59.06 (3.3% risk)
- **Target:** $63.06 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 250
- **Position Value:** $15,265.00
- **Portfolio %:** 15.27%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-09 (Est: $0.38)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.42 | $0.37 | -11.5% |
| 2025Q2 | $0.30 | $0.34 | +12.6% |
| 2025Q1 | $0.27 | $0.26 | -4.9% |
| 2024Q4 | $0.40 | $0.26 | -35.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*